Decision confirms the therapeutic value of Pemazyre® (pemigatinib) and need for new approaches to treat advanced cholangiocarcinoma (bile duct cancer) INESSS positive recommendation is an important milestone towards public funding for… Read More
People with addiction challenges are getting better, seamless treatment and recovery care through the new Road to Recovery initiative at St. Paul’s Hospital in Vancouver. “The moment a person living with… Read More
VANCOUVER, BC — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced the closing of its previously announced underwritten public offering of 9,846,157 common shares, which includes 1,384,615 shares sold… Read More
“I say yes to participate in research because it is a way to engage in my community and support other people.” – NATE*, VANCOUVER For Nate*, the many gambling facilities… Read More
WELL Ventures is pleased to report that its portfolio companies continue to raise funds at attractive valuations with high quality capital allocators globally. Sun Life has invested $9.5 million in… Read More
